Understanding the risk of NMS in young patients

Welcome to the latest edition of Investigative Roundup, highlighting some of the best investigative reporting on healthcare each week. U.S. Suspends Wuhan Lab’s Funding The

The FDA re­ject­ed Zealand Phar­ma’s glucagon re­cep­tor ag­o­nist in con­gen­i­tal hy­per­in­sulin­ism (CHI) af­ter iden­ti­fy­ing prob­lems at a third-par­ty man­u­fac­tur­ing site. The com­pa­ny said it re­mains

Oral glucose-lowering medications weren’t up to snuff with insulin for gestational diabetes, a randomized clinical trial found. Among 820 individuals, 23.9% of infants born to